Search research articles
Contact Us
Filters
Showing results (1-10 of 73) with videos related to
Page
of 8
Sort By:
Journal of Gastroenterology and Hepatology
|
April 5, 2021
Head-to-head trials in inflammatory bowel disease
Graham Radford-Smith
World Journal of Gastroenterology
|
November 30, 2006
Associations between NOD2/CARD15 genotype and phenotype in Crohn's disease--Are we there yet?
Graham Radford-Smith, Nirmala Pandeya
Alimentary Pharmacology & Therapeutics
|
December 28, 2020
Letter: hidden costs in healthcare use for incident and prevalent Crohn's disease and ulcerative colitis
Anton Lord, Graham Radford-Smith
Gastroenterology
|
March 29, 2012
Clinical remission after stopping infliximab in Crohn's disease: is all that glitters true gold?
Dario Sorrentino, Graham Radford-Smith
The American Journal of Gastroenterology
|
June 9, 2015
Response to Magro et al
James Irwin, Graham Radford-Smith
Nature Clinical Practice. Gastroenterology & Hepatology
|
February 3, 2007
How useful are biomarkers for the prediction of short-term relapse in patients with Crohn's disease?
Graham Radford-Smith, Peter O'Rourke
Alimentary Pharmacology & Therapeutics
|
September 5, 2020
Editorial: obesity management and IBD-weight loss reduces IBD risk
Abigail Marsh, Graham Radford-Smith
Alimentary Pharmacology & Therapeutics
|
April 26, 2022
Editorial: is older-onset ulcerative colitis more severe or less aggressively managed?
Richard G Fernandes, Graham Radford-Smith
Journal of Crohn'S & Colitis
|
February 11, 2022
Markers of Systemic Inflammation in Acute Attacks of Ulcerative Colitis: What Level of C-reactive Protein Constitutes Severe Colitis?
Anthony Croft, Anton Lord, Graham Radford-Smith
Internal Medicine Journal
|
September 25, 2020
Delivering inflammatory bowel disease care across distance
Ming Han Lim, Anna McMahon, Graham Radford-Smith
Page
of 8
Search research articles
Search
Showing results (1-10 of 73) with videos related to
Sort By:
Page
of 8
Journal of Gastroenterology and Hepatology
|
April 5, 2021
Head-to-head trials in inflammatory bowel disease
Graham Radford-Smith
World Journal of Gastroenterology
|
November 30, 2006
Associations between NOD2/CARD15 genotype and phenotype in Crohn's disease--Are we there yet?
Graham Radford-Smith, Nirmala Pandeya
Alimentary Pharmacology & Therapeutics
|
December 28, 2020
Letter: hidden costs in healthcare use for incident and prevalent Crohn's disease and ulcerative colitis
Anton Lord, Graham Radford-Smith
Gastroenterology
|
March 29, 2012
Clinical remission after stopping infliximab in Crohn's disease: is all that glitters true gold?
Dario Sorrentino, Graham Radford-Smith
The American Journal of Gastroenterology
|
June 9, 2015
Response to Magro et al
James Irwin, Graham Radford-Smith
Nature Clinical Practice. Gastroenterology & Hepatology
|
February 3, 2007
How useful are biomarkers for the prediction of short-term relapse in patients with Crohn's disease?
Graham Radford-Smith, Peter O'Rourke
Alimentary Pharmacology & Therapeutics
|
September 5, 2020
Editorial: obesity management and IBD-weight loss reduces IBD risk
Abigail Marsh, Graham Radford-Smith
Alimentary Pharmacology & Therapeutics
|
April 26, 2022
Editorial: is older-onset ulcerative colitis more severe or less aggressively managed?
Richard G Fernandes, Graham Radford-Smith
Journal of Crohn'S & Colitis
|
February 11, 2022
Markers of Systemic Inflammation in Acute Attacks of Ulcerative Colitis: What Level of C-reactive Protein Constitutes Severe Colitis?
Anthony Croft, Anton Lord, Graham Radford-Smith
Internal Medicine Journal
|
September 25, 2020
Delivering inflammatory bowel disease care across distance
Ming Han Lim, Anna McMahon, Graham Radford-Smith
Page
of 8